# GSK receives FDA approval for Boostrix for immunisation during pregnancy

- Link: https://www.directorstalkinterviews.com/gsk-receives-fda-approval-for-boostrix-for-immunisation-during-pregnancy/4121085654
- Published: 2022-10-10T07:37:00+01:00
- Author: Amilia Stone

**[GSK plc](https://www.directorstalkinterviews.com/ftse-company/glaxosmithkline-plc/gsk.l)**(
[LON:GSK](https://www.directorstalkinterviews.com/ftse-company/glaxosmithkline-plc/gsk.l),
NYSE:GSK) has announced that the US Food and Drug Administration (FDA) has approved
_Boostrix_ (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine
adsorbed [Tdap]) for immunisation during the third trimester of pregnancy to help
prevent pertussis (whooping cough) in infants less than two months of age.

Since 2010, the Centers for Disease Control and Prevention (CDC) has reported 15,000
to 48,000 pertussis cases among people of all ages in the United States each year.
^(1) Infants are at high risk of complications from whooping cough because their
immune systems are still developing.^(1)

According to the CDC, the Tdap vaccination given during pregnancy provides the best
protection to infants against whooping cough. Vaccination passes protective antibodies
to babies before birth to protect them in their first months of life^(2).

**About BOOSTRIX**

_Boostrix_ is indicated in the US for:

·      Active booster immunisation against tetanus, diphtheria and pertussis in 
individuals aged 10 years and older.

·      Immunisation during the third trimester of pregnancy to help prevent pertussis(
whooping cough) in infants less than two months of age.

> **Roger Connor, President, Vaccines and Global Health, GSK, said:** “We’re immensely
> proud to have the first-ever Tdap vaccine approved by the FDA specifically for
> use during pregnancy. We believe this approval may help protect more infants from
> the potentially life-threatening implications of whooping cough.”
> _Boostrix_ is currently approved in over 80 countries worldwide, including the
> US, most European Union countries, Canada, Australia and New Zealand for immunisation
> against tetanus, diphtheria and pertussis.

Share on: